Adjuvant chemotherapy for rectal cancer

Annals of Oncology

Volumn 21, Issue 12, 2010, Pages 2443-

  Bujko, K ^a   Glynne Jones, R ^b   Bujko, M ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CLINICAL TRIAL; HUMAN; LETTER; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED PRACTICE; FOLLOW-UP STUDIES; HUMANS; MEDICAL FUTILITY; NEOPLASM METASTASIS; POSTOPERATIVE CARE; RECTAL NEOPLASMS; REVIEW LITERATURE AS TOPIC; SURVIVAL ANALYSIS;

EID: 78649462936     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq616     Document Type: Letter

References (3)

1. Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radio(chemo)therapy? A systematic review of randomized trials. Ann Oncol 2010; 21: 1743-1750.
2. Cionini L, Sainato A, De Paoli A, et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. Radiother Oncol 2010; 96 (Suppl 1): S113-S114 (Abstr).
3. Bosset JF, Collette L, Calais G, et al. Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123